GlobeStar Therapeutics Corporation (GSTC)
OTCMKTS · Delayed Price · Currency is USD
0.00001
0.00 (0.00%)
At close: Nov 17, 2026
GlobeStar Therapeutics Market Cap
GlobeStar Therapeutics has a market cap or net worth of $12.41 thousand as of November 20, 2026. It is the 51,860th most valuable company in the world and the 7,740th biggest in the United States. Its market cap has increased by 900.08% in one year.
Market Cap
12.41K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#7,740 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 23, 2016, GlobeStar Therapeutics's market cap has decreased from 1.06M to 12.41K, a decrease of -98.83%. That is a compound annual growth rate of -34.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 1.24K | - |
| Dec 31, 2025 | 1.24K | -99.60% |
| Dec 31, 2024 | 310.28K | -66.41% |
| Dec 29, 2023 | 923.78K | -90.98% |
| Dec 30, 2022 | 10.25M | 47.12% |
| Dec 31, 2021 | 6.96M | 102.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biostax | 21.65K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Bio-Path Holdings | 16.17K |
| Scorpius Holdings | 12.23K |
| GeneLink | 10.60K |
| Navidea Biopharmaceuticals | 10.00K |
| Windtree Therapeutics | 9.00K |